HCA Healthcare, Inc. $HCA Shares Purchased by LGT Fund Management Co Ltd.

LGT Fund Management Co Ltd. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,420 shares of the company’s stock after acquiring an additional 68 shares during the period. HCA Healthcare comprises 0.9% of LGT Fund Management Co Ltd.’s holdings, making the stock its 25th largest position. LGT Fund Management Co Ltd.’s holdings in HCA Healthcare were worth $10,505,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Park Place Capital Corp increased its holdings in shares of HCA Healthcare by 2,336.0% in the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after purchasing an additional 1,168 shares during the last quarter. Harrell Investment Partners LLC increased its holdings in shares of HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares during the last quarter. Brown Advisory Inc. increased its stake in HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in HCA Healthcare by 26.9% during the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after acquiring an additional 242 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research note on Saturday, September 27th. Robert W. Baird boosted their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 10th. Truist Financial boosted their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. Finally, Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $407.75.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $429.52 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $432.36. The company has a market capitalization of $100.50 billion, a price-to-earnings ratio of 18.05, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. The business has a 50-day moving average of $397.53 and a two-hundred day moving average of $372.39.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $5.50 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.